2484719-14-2Abiraterone Ethyl Ether Impurity
● Under Development
| 카탈로그 번호: | VL830020 |
|---|---|
| CAS 번호: | 2484719-14-2 |
| 분자식: | C26H35NO |
| 분자량: | 377.57 g/mol |
에 대한 추가 정보 CAS 2484719-14-2
모약물
AbirateroneIUPAC명
3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine약전 동의어
N/AOther Synonyms
N/ASMILES
C[C@@]12C(C3=CC=CN=C3)=CC[C@@]1([H])[C@]4([H])CC=C5C[C@@H](OCC)CC[C@]5(C)[C@@]4([H])CC2InChI
InChI=1S/C26H35NO/c1-4-28-20-11-13-25(2)19(16-20)7-8-21-23-10-9-22(18-6-5-15-27-17-18)26(23,3)14-12-24(21)25/h5-7,9,15,17,20-21,23-24H,4,8,10-14,16H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1설명
Abiraterone Ethyl Ether Impurity or 1-((8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl)ethan-1-one,is a derivative of steroidal progesterone and is used in the treatment of prostate cancer.References
Thakur, Abhimanyu, et al. “Abiraterone Acetate in the Treatment of Prostate Cancer.†Biomedicine & Pharmacotherapy, vol. 101, May 2018, pp. 211–218, 10.1016/j.biopha.2018.02.067.견적 요청
"*" indicates required fields









